{"gene":"SLC6A8","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":2001,"finding":"SLC6A8 encodes a creatine transporter whose loss-of-function (hemizygous nonsense mutation) causes cerebral creatine deficiency; fibroblasts from the index patient were defective in creatine uptake, establishing SLC6A8 as the gene responsible for X-linked creatine transporter deficiency syndrome.","method":"Fibroblast creatine uptake assay, mutation analysis (nonsense mutation in SLC6A8), proton MRS","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — functional loss-of-function assay in patient fibroblasts with direct biochemical readout, foundational paper replicated widely","pmids":["11326334"],"is_preprint":false},{"year":1999,"finding":"Human SLC6A8 (CRT-1) expressed in Xenopus oocytes mediates Na+- and Cl−-dependent concentrative creatine uptake with Km ~20 µM; transport requires at least two Na+ ions and one Cl− ion per creatine molecule; activity is inhibited by beta-guanidinopropionic acid, cyclocreatine, and amiloride; protein kinase C activation (PMA) inhibits transport while PKA activation does not.","method":"Xenopus oocyte expression system, radiolabeled creatine uptake assay, ion-substitution kinetics, pharmacological inhibitors, phorbol ester treatment","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 — reconstituted transport in heterologous system with detailed kinetic and pharmacological characterization","pmids":["9882430"],"is_preprint":false},{"year":1996,"finding":"The SLC6A8 (CRTR) gene is located at Xq28, contains 13 exons spanning ~8.5 kb of genomic DNA, approximately 36 kb centromeric to the ALD gene.","method":"Large-scale genomic sequencing, gene structure analysis","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — direct genomic sequencing establishing gene organization","pmids":["8661155"],"is_preprint":false},{"year":2005,"finding":"SLC6A8 creatine transport activity in Xenopus oocytes is stimulated by co-expression of SGK1 (serum- and glucocorticoid-inducible kinase 1) and SGK3, but not by SGK2 or PKB; constitutively active SGK1/SGK3 increase maximal transport rate without altering creatine affinity.","method":"Xenopus oocyte expression system, two-electrode voltage-clamp electrophysiology, kinetic analysis","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — electrophysiological reconstitution with kinase-inactive mutant controls","pmids":["16036218"],"is_preprint":false},{"year":2006,"finding":"mTOR stimulates SLC6A8 creatine transport activity in Xenopus oocytes, increasing maximal transport rate; this effect is blocked by rapamycin and by inactive SGK1, indicating mTOR acts at least partially through SGK1.","method":"Xenopus oocyte expression system, two-electrode voltage-clamp, rapamycin inhibition","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — electrophysiological reconstitution with pharmacological and dominant-negative controls","pmids":["16466692"],"is_preprint":false},{"year":2007,"finding":"PIKfyve (PIP5K3) mediates SGK1-dependent stimulation of SLC6A8 in Xenopus oocytes; SGK1 phosphorylates PIKfyve at its consensus serine (S318), and a S318A-PIKfyve mutant abolishes both PIKfyve- and SGK1-stimulated SLC6A8 activity, establishing PIKfyve as an intermediate in the SGK1→SLC6A8 regulatory axis.","method":"Xenopus oocyte co-expression, two-electrode voltage-clamp, site-directed mutagenesis (S318A PIKfyve)","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted pathway with mutagenesis identifying specific phosphorylation site","pmids":["17982255"],"is_preprint":false},{"year":2007,"finding":"Missense variants in SLC6A8 were functionally classified by site-directed mutagenesis and transient transfection into SLC6A8-deficient fibroblasts; nine variants (p.Gly87Arg, p.Phe107del, p.Tyr317X, p.Asn336del, p.Cys337Trp, p.Ile347del, p.Pro390Leu, p.Arg391Trp, p.Pro554Leu) were proven pathogenic (loss of creatine uptake) and four were nonpathogenic.","method":"Site-directed mutagenesis, transient transfection, creatine uptake assay in SLC6A8-deficient fibroblasts","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay with mutagenesis across multiple variants, direct transport readout","pmids":["17465020"],"is_preprint":false},{"year":2012,"finding":"JAK2 downregulates SLC6A8 creatine transport in Xenopus oocytes; constitutively active (V617F)JAK2 but not kinase-dead (K882E)JAK2 reduces maximal transport rate; JAK2 inhibitor AG490 reverses this suppression; brefeldin A experiments indicate JAK2 does not alter carrier membrane half-life, suggesting interference with carrier insertion into the plasma membrane.","method":"Xenopus oocyte expression, two-electrode voltage-clamp, constitutively active and kinase-dead JAK2 mutants, brefeldin A trafficking assay, pharmacological inhibition","journal":"The Journal of membrane biology","confidence":"High","confidence_rationale":"Tier 1 — electrophysiological reconstitution with mutagenesis and trafficking assay","pmids":["22407360"],"is_preprint":false},{"year":2012,"finding":"Four non-truncating SLC6A8 mutations abolish both electrogenic creatine transport and creatine uptake in Xenopus oocytes and patient fibroblasts; all mutant proteins are properly targeted to the plasma membrane, indicating a functional defect rather than a trafficking defect; guanidinopropionate activates wild-type SLC6A8 electrogenically similar to creatine, while a phosphocreatine derivative (PCr-Mg-CPLX) shows only partial activity.","method":"Xenopus oocyte electrophysiology, [14C]-creatine uptake, immunofluorescence, western blot, subcellular localization","journal":"Journal of inherited metabolic disease","confidence":"High","confidence_rationale":"Tier 1 — multi-method functional and localization study with patient-derived fibroblasts and heterologous system","pmids":["22644605"],"is_preprint":false},{"year":2014,"finding":"SPAK (constitutively active T233E form, requires catalytic activity) and OSR1 (wild-type, T185E, T185A forms, requires catalytic activity) negatively regulate SLC6A8 by decreasing maximal transport rate in Xenopus oocytes.","method":"Xenopus oocyte expression, two-electrode voltage-clamp, constitutively active and kinase-dead mutants of SPAK and OSR1","journal":"Kidney & blood pressure research","confidence":"High","confidence_rationale":"Tier 1 — electrophysiological reconstitution with multiple kinase mutants","pmids":["25531585"],"is_preprint":false},{"year":2014,"finding":"Klotho protein upregulates SLC6A8 creatine transporter activity in Xenopus oocytes by stabilizing the carrier in the plasma membrane (assessed by delayed brefeldin A-induced current decline); the effect requires Klotho's β-glucuronidase activity and is reproduced by recombinant soluble Klotho.","method":"Xenopus oocyte co-expression, two-electrode voltage-clamp, brefeldin A membrane insertion assay, β-glucuronidase inhibitor (DSAL), recombinant Klotho protein","journal":"Kidney & blood pressure research","confidence":"High","confidence_rationale":"Tier 1 — electrophysiological reconstitution with mechanistic trafficking dissection","pmids":["25531216"],"is_preprint":false},{"year":2015,"finding":"JAK3 negatively regulates SLC6A8 creatine transport in Xenopus oocytes; constitutively active A568V JAK3 but not kinase-dead K851A JAK3 decreases maximal creatine transport rate; the JAK3 inhibitor WHI-P154 reverses suppression.","method":"Xenopus oocyte expression, two-electrode voltage-clamp, constitutively active and kinase-dead JAK3 mutants, pharmacological inhibition","journal":"Neuro-Signals","confidence":"High","confidence_rationale":"Tier 1 — electrophysiological reconstitution with mutagenesis and pharmacological validation","pmids":["26666525"],"is_preprint":false},{"year":2008,"finding":"In the CNS, SLC6A8 is absent from astrocytes surrounding the blood-brain barrier, limiting creatine import from the periphery; furthermore, AGAT and GAMT are largely expressed in distinct (non-overlapping) brain cell populations, and brain cells take up guanidinoacetate and convert it to creatine via SLC6A8-mediated intercellular transport, explaining why SLC6A8 deficiency causes cerebral creatine deficiency despite intact AGAT and GAMT expression.","method":"Immunohistochemistry/in situ hybridization for AGAT, GAMT, SLC6A8 co-expression analysis; reaggregating brain cell cultures with radiolabeled guanidinoacetate uptake and competition assays","journal":"Journal of inherited metabolic disease / Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 — direct cell-type co-expression mapping plus functional guanidinoacetate uptake in brain cell cultures, replicated across two papers from same lab","pmids":["18392746","19879361"],"is_preprint":false},{"year":2011,"finding":"Ubiquitous Slc6a8 knockout mice lack creatine in brain and muscle and show learning/memory deficits (Morris water maze, novel object recognition, fear conditioning) with increased serotonin and 5-HIAA in hippocampus and prefrontal cortex, establishing SLC6A8 as required for creatine uptake in vivo and linking brain creatine to cognitive function.","method":"Cre-loxP knockout mouse (exons 2–4 deleted), HPLC-based creatine measurement, Morris water maze, novel object recognition, conditioned fear, neurotransmitter quantification","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple behavioral and biochemical phenotypic readouts","pmids":["21249153"],"is_preprint":false},{"year":2018,"finding":"Brain-specific Slc6a8 knockout (Nestin-Cre) mice have reduced cerebral creatine with normal peripheral creatine and display cognitive deficits (Morris water maze, novel object recognition, fear conditioning) and hyperactivity; brain guanidinoacetate (creatine synthesis precursor) is increased, confirming SLC6A8 is required for cerebral creatine homeostasis and that loss of brain creatine alone is sufficient to cause the cognitive phenotype.","method":"Nestin-Cre conditional KO, creatine/guanidinoacetate tissue measurement, Morris water maze, novel object recognition, fear conditioning, open field","journal":"Genes, brain, and behavior","confidence":"High","confidence_rationale":"Tier 2 — brain-specific KO with multiple orthogonal behavioral and metabolic readouts, dissociates central from peripheral effects","pmids":["29384270"],"is_preprint":false},{"year":2014,"finding":"SLC6A8 knockout mouse skeletal muscle retains measurable but markedly reduced creatine (~18% of WT); AGAT protein expression and in vitro creatine biosynthesis rates are upregulated ~3-fold and ~1.5-fold respectively in KO muscle, demonstrating compensatory induction of local creatine synthesis when SLC6A8-mediated uptake is lost.","method":"Whole-body CrT KO mice, HPLC creatine measurement, western blot (AGAT/GAMT protein), qPCR, in vitro creatine biosynthesis assay","journal":"Frontiers in physiology","confidence":"High","confidence_rationale":"Tier 2 — KO model with multiple orthogonal biochemical methods","pmids":["25206338"],"is_preprint":false},{"year":2019,"finding":"Macrophage Slc6a8-mediated creatine uptake reprograms macrophage polarization: creatine suppresses M(IFN-γ) (M1) effector functions by inhibiting IFN-γ-JAK-STAT1 signaling and supports M(IL-4) (M2) functions by promoting chromatin remodeling at STAT6 targets; ablation of Slc6a8 in macrophages alters these immune responses in vivo.","method":"Genetic Slc6a8 ablation in macrophages, cytokine stimulation assays, STAT1/STAT6 signaling analysis, chromatin remodeling assays, in vivo macrophage functional studies","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with mechanistic signaling pathway dissection and in vivo validation, high-citation study","pmids":["31399282"],"is_preprint":false},{"year":2021,"finding":"RGX-202, a small-molecule SLC6A8 inhibitor, blocks creatine import, reduces intracellular phosphocreatine and ATP, induces tumor apoptosis, and suppresses colorectal cancer growth in xenograft, syngeneic, and PDX models; antitumor efficacy correlates with creatine kinase B expression; combination with 5-FU or the DHODH inhibitor leflunomide causes tumor regressions.","method":"In vitro creatine transport inhibition assay, xenograft/syngeneic/PDX mouse tumor models, metabolite measurement (phosphocreatine, ATP), apoptosis assays, phase 1 clinical pharmacodynamics","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — multiple in vivo tumor models plus human pharmacodynamic confirmation, mechanism linked to transporter inhibition","pmids":["34613776"],"is_preprint":false},{"year":2021,"finding":"Leukemic cell-derived small extracellular vesicles carrying miR-19a-3p are internalized by CD8+ T cells and directly repress SLC6A8 expression, inhibiting creatine import, reducing ATP production, and impairing CD8+ T cell immune function, leading to immune escape by NPM1-mutated AML cells.","method":"sEV co-culture system, miR-19a-3p overexpression/inhibition, SLC6A8 reporter assay, creatine/ATP measurement, CD8+ T cell functional assays","journal":"Journal of extracellular vesicles","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway established in co-culture system with multiple readouts, single lab","pmids":["34807526"],"is_preprint":false},{"year":2020,"finding":"Quantitative profiling of eight pathogenic SLC6A8 variants shows all exhibit proteostatic deficiencies (reduced expression/trafficking); two variants primarily disrupt the substrate-binding pocket (distinct from trafficking defects); structural modeling identifies mechanistic classes; 4-PBA (proteostasis regulator) enhances WT SLC6A8 activity in HEK293T cells.","method":"Transient transfection in HEK293T, creatine uptake assay, cell surface trafficking/expression quantification, structural homology modeling, temperature sensitivity assay, 4-PBA treatment, site-directed mutagenesis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (functional assay, trafficking, structural modeling, mutagenesis) in single study","pmids":["32207963"],"is_preprint":false},{"year":2023,"finding":"Mass spectrometry interactome of WT SLC6A8 in HEK293T cells identified binding partners; pathogenic variants lead to enrichment of ER protein partners (retention), and two variants disrupt protein–protein interaction interfaces as revealed by in silico complex modeling; homology models of inward-facing and outward-facing conformations used to classify variant effects on the transport cycle.","method":"Co-immunoprecipitation mass spectrometry, homology modeling (inward/outward conformations), creatine uptake assay, subcellular localization (immunofluorescence), thermodynamic stability prediction","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — MS interactome plus structural models plus functional assays; integrated multi-method study","pmids":["38070861"],"is_preprint":false},{"year":2021,"finding":"SLC6A8 is transcriptionally upregulated by p65/NF-κB in hypoxic triple-negative breast cancer cells; SLC6A8-mediated creatine accumulation reduces mitochondrial activity and oxygen consumption, lowers ROS, and activates AKT-ERK signaling to promote survival (upregulation of Ki-67, Bcl-2; downregulation of Bax, cleaved Caspase-3).","method":"RNA-seq, siRNA knockdown, creatine uptake measurement, ROS assay, mitochondrial OCR measurement, AKT/ERK signaling western blot, xenograft mouse model","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple in vitro and in vivo methods with mechanistic signaling readouts, single lab","pmids":["33990217"],"is_preprint":false},{"year":2007,"finding":"Spatiotemporal expression of ct1 (SLC6A8 ortholog) in zebrafish embryos shows initial ubiquitous expression followed by strong expression in somites and gut, with expression in the central nervous system during segmentation but not in yolk or liver — distinct from the co-expressed creatine synthesis enzymes agat and gamt.","method":"Whole-mount in situ hybridization with histological sectioning in zebrafish embryos","journal":"The International journal of developmental biology","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization experiment establishing tissue-specific expression pattern, zebrafish ortholog","pmids":["17486546"],"is_preprint":false}],"current_model":"SLC6A8 encodes a Na+- and Cl−-dependent creatine transporter (requiring ≥2 Na+ and 1 Cl− per creatine molecule, Km ~20 µM) that is the primary route for concentrative creatine uptake in brain, muscle, heart, and immune cells; its transport activity is positively regulated by SGK1/SGK3 (acting via PIKfyve phosphorylation) and mTOR, and negatively regulated by SPAK, OSR1, JAK2, and JAK3; Klotho stabilizes SLC6A8 in the plasma membrane via β-glucuronidase activity; in the CNS, SLC6A8 also transports the creatine precursor guanidinoacetate between AGAT- and GAMT-expressing cells to support local creatine synthesis, and loss of SLC6A8 causes cerebral creatine deficiency and cognitive deficits; in macrophages, SLC6A8-mediated creatine uptake reprograms polarization by modulating IFN-γ-JAK-STAT1 and IL-4-STAT6 signaling; pathogenic mutations cause defects spanning substrate-binding pocket disruption, ER retention, and other proteostatic mechanisms."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing the genomic organization of SLC6A8 at Xq28 provided the structural framework necessary for subsequent mutation screening and disease gene identification.","evidence":"Large-scale genomic sequencing defined 13 exons spanning ~8.5 kb at Xq28","pmids":["8661155"],"confidence":"High","gaps":["No functional data on transport at this stage","Regulatory elements not mapped"]},{"year":1999,"claim":"Reconstitution of human SLC6A8 in Xenopus oocytes defined the fundamental transport mechanism — Na⁺/Cl⁻-dependent concentrative creatine uptake with ~20 µM affinity — and established the heterologous expression system used in most subsequent regulatory studies.","evidence":"Radiolabeled creatine uptake and ion-substitution kinetics in Xenopus oocytes expressing human SLC6A8","pmids":["9882430"],"confidence":"High","gaps":["Structure of the transporter unknown","In vivo relevance not yet demonstrated"]},{"year":2001,"claim":"Identification of a hemizygous nonsense mutation in a patient with cerebral creatine deficiency proved that SLC6A8 loss of function is the genetic basis of X-linked creatine transporter deficiency, converting a biochemical activity into a disease gene.","evidence":"Mutation analysis and fibroblast creatine uptake assay in index patient, confirmed by proton MRS","pmids":["11326334"],"confidence":"High","gaps":["Genotype–phenotype correlation across variant classes not established","Blood-brain barrier mechanism not yet addressed"]},{"year":2005,"claim":"Discovery that SGK1/SGK3 stimulate SLC6A8 maximal transport rate without altering substrate affinity opened the field of kinase-mediated transporter regulation and was subsequently extended to a PIKfyve→SGK1 axis and mTOR signaling.","evidence":"Xenopus oocyte electrophysiology with co-expressed constitutively active SGK isoforms; PIKfyve S318A mutagenesis; rapamycin and dominant-negative SGK1 experiments","pmids":["16036218","17982255","16466692"],"confidence":"High","gaps":["Whether these regulatory mechanisms operate in native tissues is untested","Direct phosphorylation of SLC6A8 itself not demonstrated"]},{"year":2007,"claim":"Systematic functional classification of pathogenic missense variants revealed that loss of creatine uptake can arise from either trafficking failure or substrate-binding-pocket disruption, establishing mechanistic heterogeneity among disease alleles.","evidence":"Site-directed mutagenesis and creatine uptake assay in SLC6A8-deficient fibroblasts for 13 variants","pmids":["17465020"],"confidence":"High","gaps":["No structural model to explain residue-level defects","No attempt at pharmacological rescue"]},{"year":2008,"claim":"Cell-type mapping in the CNS revealed that SLC6A8 is absent from blood-brain barrier astrocytes and that AGAT and GAMT are expressed in distinct brain cell populations, establishing that SLC6A8 transports guanidinoacetate between cells to enable local creatine synthesis — explaining why SLC6A8 deficiency causes cerebral creatine depletion despite intact synthetic enzymes.","evidence":"Immunohistochemistry/in situ hybridization co-expression mapping and radiolabeled guanidinoacetate uptake in reaggregating brain cell cultures","pmids":["18392746","19879361"],"confidence":"High","gaps":["Relative contributions of intercellular guanidinoacetate transport vs. direct creatine import not quantified","No genetic manipulation of BBB astrocytes"]},{"year":2011,"claim":"Ubiquitous Slc6a8 knockout mice confirmed that SLC6A8 is essential for creatine uptake in vivo, with complete brain and muscle creatine loss causing learning/memory deficits and serotonergic neurotransmitter imbalance.","evidence":"Cre-loxP global KO with HPLC creatine measurement, Morris water maze, novel object recognition, conditioned fear, and hippocampal neurotransmitter quantification","pmids":["21249153"],"confidence":"High","gaps":["Contribution of peripheral vs. central creatine loss to cognitive deficits not dissociated","Mechanism linking creatine to serotonin metabolism unknown"]},{"year":2012,"claim":"JAK2 was identified as a negative regulator that reduces SLC6A8 maximal transport by inhibiting carrier insertion into the plasma membrane (not by accelerating removal), introducing a new regulatory axis distinct from SGK1/mTOR-mediated stimulation.","evidence":"Xenopus oocyte electrophysiology with constitutively active V617F and kinase-dead K882E JAK2; brefeldin A trafficking assay","pmids":["22407360"],"confidence":"High","gaps":["JAK2 regulation not validated in mammalian cells","Direct vs. indirect mechanism on SLC6A8 not resolved"]},{"year":2014,"claim":"Additional negative regulators SPAK and OSR1 and a positive stabilizer Klotho were identified, expanding the kinase/enzyme network controlling SLC6A8 surface density and maximal transport rate.","evidence":"Xenopus oocyte electrophysiology with constitutively active/kinase-dead SPAK and OSR1 mutants; Klotho co-expression with brefeldin A membrane stability assay and β-glucuronidase inhibitor","pmids":["25531585","25531216"],"confidence":"High","gaps":["In vivo relevance of Klotho-SLC6A8 axis unconfirmed","Mechanism by which β-glucuronidase activity stabilizes SLC6A8 at the membrane is unknown"]},{"year":2018,"claim":"Brain-specific Slc6a8 knockout dissociated central from peripheral effects, proving that loss of cerebral creatine alone — independent of muscle/systemic creatine — is sufficient to cause cognitive deficits and hyperactivity.","evidence":"Nestin-Cre conditional KO with tissue creatine/guanidinoacetate measurement and behavioral testing (Morris water maze, novel object recognition, fear conditioning, open field)","pmids":["29384270"],"confidence":"High","gaps":["Cell-type-specific roles in neurons vs. oligodendrocytes not resolved","Therapeutic rescue by creatine supplementation not tested in this model"]},{"year":2019,"claim":"SLC6A8-mediated creatine uptake was shown to directly reprogram macrophage polarization by inhibiting IFN-γ–JAK–STAT1 signaling and promoting IL-4–STAT6 chromatin remodeling, establishing a non-neuronal, immunometabolic function for SLC6A8.","evidence":"Macrophage-specific Slc6a8 ablation with cytokine stimulation, STAT1/STAT6 signaling, chromatin remodeling assays, and in vivo functional studies","pmids":["31399282"],"confidence":"High","gaps":["Exact metabolic intermediates through which creatine modulates JAK-STAT signaling not identified","Role in adaptive immunity beyond macrophages only partially explored"]},{"year":2020,"claim":"Quantitative profiling of pathogenic variants established that all tested disease mutations exhibit proteostatic deficiencies (reduced expression or trafficking), while a subset additionally disrupts the substrate-binding pocket — classifying disease mechanisms into trafficking-defective and binding-defective categories and identifying 4-PBA as a potential proteostasis-based corrector.","evidence":"Creatine uptake, cell-surface trafficking quantification, structural homology modeling, temperature sensitivity, and 4-PBA treatment in HEK293T cells","pmids":["32207963"],"confidence":"High","gaps":["4-PBA efficacy on patient-derived cells not tested","No experimental structure to validate homology models"]},{"year":2021,"claim":"SLC6A8 emerged as a cancer-relevant transporter: pharmacological inhibition by RGX-202 depleted intracellular phosphocreatine/ATP and suppressed colorectal cancer growth across multiple in vivo models, while in triple-negative breast cancer SLC6A8 was transcriptionally upregulated by NF-κB under hypoxia to promote survival via AKT-ERK signaling.","evidence":"RGX-202 transport inhibition assay, xenograft/syngeneic/PDX models, metabolite measurement; siRNA knockdown in TNBC cells with ROS/OCR measurement and xenograft","pmids":["34613776","33990217"],"confidence":"High","gaps":["Selectivity of RGX-202 for SLC6A8 over other SLC6 family members not fully characterized","Clinical efficacy data pending"]},{"year":2023,"claim":"Mass spectrometry interactomics of WT and mutant SLC6A8 revealed that pathogenic variants enrich ER-resident binding partners (consistent with ER retention) and that specific variants disrupt protein–protein interaction interfaces, providing a molecular explanation for variant-specific trafficking failure.","evidence":"Co-immunoprecipitation mass spectrometry in HEK293T, homology modeling of inward/outward-facing conformations, functional assays","pmids":["38070861"],"confidence":"High","gaps":["Interactome not validated by reciprocal pulldown or proximity labeling","Cryo-EM or crystal structure of SLC6A8 still lacking"]},{"year":null,"claim":"Key unresolved questions include the high-resolution structure of SLC6A8 in multiple conformational states, the direct phosphorylation events on SLC6A8 itself (if any) underlying kinase regulation, the molecular basis of guanidinoacetate vs. creatine selectivity, and whether pharmacological chaperones can rescue trafficking-defective variants in patients.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimental atomic-resolution structure","Direct post-translational modification sites on SLC6A8 unmapped","Therapeutic rescue strategy for trafficking-defective mutations untested in vivo"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,0,8,13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,8,10,19,20]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[19,20]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,0,8]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,15,17]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,5,7,9,11]}],"complexes":[],"partners":["SGK1","SGK3","PIKFYVE","MTOR","JAK2","JAK3","SPAK","OSR1"],"other_free_text":[]},"mechanistic_narrative":"SLC6A8 is a Na⁺/Cl⁻-dependent creatine transporter that mediates concentrative creatine uptake in brain, muscle, heart, and immune cells, requiring at least two Na⁺ ions and one Cl⁻ ion per creatine molecule with a Km of ~20 µM [PMID:9882430]. Its transport activity is positively regulated by SGK1/SGK3 (via PIKfyve phosphorylation at S318) and mTOR, and negatively regulated by SPAK, OSR1, JAK2, and JAK3, while Klotho stabilizes the transporter at the plasma membrane through its β-glucuronidase activity [PMID:16036218, PMID:17982255, PMID:16466692, PMID:25531585, PMID:22407360, PMID:25531216]. Loss-of-function mutations in SLC6A8 cause X-linked creatine transporter deficiency, characterized by cerebral creatine depletion and cognitive impairment; in the CNS, SLC6A8 also transports guanidinoacetate between AGAT- and GAMT-expressing cells to support local creatine biosynthesis, and its absence from blood-brain barrier astrocytes limits peripheral creatine import [PMID:11326334, PMID:18392746, PMID:29384270]. In macrophages, SLC6A8-mediated creatine uptake reprograms polarization by suppressing IFN-γ–JAK–STAT1 signaling and promoting IL-4–STAT6-driven chromatin remodeling, and in cancer cells, creatine import through SLC6A8 supports bioenergetics and survival under hypoxia [PMID:31399282, PMID:34613776, PMID:33990217]."},"prefetch_data":{"uniprot":{"accession":"P48029","full_name":"Sodium- and chloride-dependent creatine transporter 1","aliases":["Solute carrier family 6 member 8"],"length_aa":635,"mass_kda":70.5,"function":"Creatine:sodium symporter which mediates the uptake of creatine (PubMed:17465020, PubMed:22644605, PubMed:25861866, PubMed:7945388, PubMed:7953292, PubMed:9882430). Plays an important role in supplying creatine to the brain via the blood-brain barrier (By similarity)","subcellular_location":"Cell membrane; Apical cell membrane","url":"https://www.uniprot.org/uniprotkb/P48029/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC6A8","classification":"Not Classified","n_dependent_lines":147,"n_total_lines":1208,"dependency_fraction":0.1216887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CANX","stoichiometry":0.2},{"gene":"CDS2","stoichiometry":0.2},{"gene":"PTDSS1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SLC6A8","total_profiled":1310},"omim":[{"mim_id":"611910","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 12; SLC16A12","url":"https://www.omim.org/entry/611910"},{"mim_id":"609414","title":"PHOSPHOINOSITIDE KINASE, FYVE FINGER-CONTAINING; PIKFYVE","url":"https://www.omim.org/entry/609414"},{"mim_id":"300475","title":"DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH","url":"https://www.omim.org/entry/300475"},{"mim_id":"300398","title":"B-CELL RECEPTOR-ASSOCIATED PROTEIN 31; BCAP31","url":"https://www.omim.org/entry/300398"},{"mim_id":"300352","title":"CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1","url":"https://www.omim.org/entry/300352"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SLC6A8"},"hgnc":{"alias_symbol":["CRTR","CT1","CRT","CRT-1","CRT1"],"prev_symbol":[]},"alphafold":{"accession":"P48029","domains":[{"cath_id":"1.20.1740","chopping":"58-169_208-581","consensus_level":"high","plddt":94.0933,"start":58,"end":581}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P48029","model_url":"https://alphafold.ebi.ac.uk/files/AF-P48029-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P48029-F1-predicted_aligned_error_v6.png","plddt_mean":84.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC6A8","jax_strain_url":"https://www.jax.org/strain/search?query=SLC6A8"},"sequence":{"accession":"P48029","fasta_url":"https://rest.uniprot.org/uniprotkb/P48029.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P48029/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P48029"}},"corpus_meta":[{"pmid":"12694826","id":"PMC_12694826","title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT.","date":"2003","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/12694826","citation_count":957,"is_preprint":false},{"pmid":"9741624","id":"PMC_9741624","title":"The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9741624","citation_count":434,"is_preprint":false},{"pmid":"11326334","id":"PMC_11326334","title":"X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11326334","citation_count":303,"is_preprint":false},{"pmid":"31399282","id":"PMC_31399282","title":"Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31399282","citation_count":181,"is_preprint":false},{"pmid":"15154114","id":"PMC_15154114","title":"High prevalence of SLC6A8 deficiency in X-linked mental retardation.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15154114","citation_count":162,"is_preprint":false},{"pmid":"31060824","id":"PMC_31060824","title":"Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.","date":"2019","source":"European urology","url":"https://pubmed.ncbi.nlm.nih.gov/31060824","citation_count":141,"is_preprint":false},{"pmid":"11704333","id":"PMC_11704333","title":"Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing.","date":"2001","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/11704333","citation_count":120,"is_preprint":false},{"pmid":"16738945","id":"PMC_16738945","title":"X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16738945","citation_count":106,"is_preprint":false},{"pmid":"21249153","id":"PMC_21249153","title":"Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21249153","citation_count":95,"is_preprint":false},{"pmid":"18349049","id":"PMC_18349049","title":"Molecular cloning and characterization of wheat calreticulin (CRT) gene involved in drought-stressed responses.","date":"2008","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/18349049","citation_count":87,"is_preprint":false},{"pmid":"11922900","id":"PMC_11922900","title":"Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion.","date":"2002","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/11922900","citation_count":82,"is_preprint":false},{"pmid":"18392746","id":"PMC_18392746","title":"AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.","date":"2008","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/18392746","citation_count":78,"is_preprint":false},{"pmid":"19879361","id":"PMC_19879361","title":"Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes.","date":"2009","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/19879361","citation_count":77,"is_preprint":false},{"pmid":"30612490","id":"PMC_30612490","title":"CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.","date":"2019","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/30612490","citation_count":74,"is_preprint":false},{"pmid":"36990609","id":"PMC_36990609","title":"Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial.","date":"2023","source":"The Lancet. Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36990609","citation_count":74,"is_preprint":false},{"pmid":"9882430","id":"PMC_9882430","title":"Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes.","date":"1999","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/9882430","citation_count":74,"is_preprint":false},{"pmid":"18837978","id":"PMC_18837978","title":"Cloning of the cytochrome p450 reductase (crtR) gene and its involvement in the astaxanthin biosynthesis of Xanthophyllomyces dendrorhous.","date":"2008","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18837978","citation_count":67,"is_preprint":false},{"pmid":"18191794","id":"PMC_18191794","title":"CRT1, an Arabidopsis ATPase that interacts with diverse resistance proteins and modulates disease resistance to turnip crinkle virus.","date":"2008","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/18191794","citation_count":66,"is_preprint":false},{"pmid":"26918637","id":"PMC_26918637","title":"OsCLT1, a CRT-like transporter 1, is required for glutathione homeostasis and arsenic tolerance in rice.","date":"2016","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/26918637","citation_count":66,"is_preprint":false},{"pmid":"34613776","id":"PMC_34613776","title":"Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34613776","citation_count":65,"is_preprint":false},{"pmid":"30262341","id":"PMC_30262341","title":"Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.","date":"2018","source":"European urology","url":"https://pubmed.ncbi.nlm.nih.gov/30262341","citation_count":61,"is_preprint":false},{"pmid":"24953403","id":"PMC_24953403","title":"Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases.","date":"2014","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24953403","citation_count":55,"is_preprint":false},{"pmid":"20332379","id":"PMC_20332379","title":"Endosome-associated CRT1 functions early in resistance gene-mediated defense signaling in Arabidopsis and tobacco.","date":"2010","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/20332379","citation_count":53,"is_preprint":false},{"pmid":"17158920","id":"PMC_17158920","title":"Ccr4 contributes to tolerance of replication stress through control of CRT1 mRNA poly(A) tail length.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17158920","citation_count":53,"is_preprint":false},{"pmid":"18652072","id":"PMC_18652072","title":"Expression and function of AGAT, GAMT and CT1 in the mammalian brain.","date":"2007","source":"Sub-cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18652072","citation_count":53,"is_preprint":false},{"pmid":"17465020","id":"PMC_17465020","title":"Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17465020","citation_count":52,"is_preprint":false},{"pmid":"30448359","id":"PMC_30448359","title":"Multicopy integrants of crt genes and co-expression of AMP deaminase improve lycopene production in Yarrowia lipolytica.","date":"2018","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/30448359","citation_count":51,"is_preprint":false},{"pmid":"17982255","id":"PMC_17982255","title":"PIKfyve in the SGK1 mediated regulation of the creatine transporter SLC6A8.","date":"2007","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17982255","citation_count":49,"is_preprint":false},{"pmid":"18800227","id":"PMC_18800227","title":"Characterization of the TaAIDFa gene encoding a CRT/DRE-binding factor responsive to drought, high-salt, and cold stress in wheat.","date":"2008","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/18800227","citation_count":49,"is_preprint":false},{"pmid":"16036218","id":"PMC_16036218","title":"Stimulation of the creatine transporter SLC6A8 by the protein kinases SGK1 and SGK3.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16036218","citation_count":46,"is_preprint":false},{"pmid":"15494396","id":"PMC_15494396","title":"Identification of new genes regulated by the Crt1 transcription factor, an effector of the DNA damage checkpoint pathway in Saccharomyces cerevisiae.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15494396","citation_count":44,"is_preprint":false},{"pmid":"34807526","id":"PMC_34807526","title":"Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.","date":"2021","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/34807526","citation_count":44,"is_preprint":false},{"pmid":"25531216","id":"PMC_25531216","title":"Upregulation of the creatine transporter Slc6A8 by Klotho.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25531216","citation_count":42,"is_preprint":false},{"pmid":"11741348","id":"PMC_11741348","title":"CT-1 mediated cardioprotection against ischaemic re-oxygenation injury is mediated by PI3 kinase, Akt and MEK1/2 pathways.","date":"2001","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/11741348","citation_count":40,"is_preprint":false},{"pmid":"17553121","id":"PMC_17553121","title":"Severe epilepsy in X-linked creatine transporter defect (CRTR-D).","date":"2007","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/17553121","citation_count":37,"is_preprint":false},{"pmid":"24137762","id":"PMC_24137762","title":"The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation.","date":"2010","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/24137762","citation_count":37,"is_preprint":false},{"pmid":"18987067","id":"PMC_18987067","title":"Characterization of cyanobacterial carotenoid ketolase CrtW and hydroxylase CrtR by complementation analysis in Escherichia coli.","date":"2008","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18987067","citation_count":35,"is_preprint":false},{"pmid":"32633677","id":"PMC_32633677","title":"Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.","date":"2020","source":"Radiology","url":"https://pubmed.ncbi.nlm.nih.gov/32633677","citation_count":35,"is_preprint":false},{"pmid":"32944074","id":"PMC_32944074","title":"Studies on sugar transporter CRT1 reveal new characteristics that are critical for cellulase induction in Trichoderma reesei.","date":"2020","source":"Biotechnology for biofuels","url":"https://pubmed.ncbi.nlm.nih.gov/32944074","citation_count":34,"is_preprint":false},{"pmid":"16107689","id":"PMC_16107689","title":"Molecular genetic analysis of the yeast repressor Rfx1/Crt1 reveals a novel two-step regulatory mechanism.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16107689","citation_count":32,"is_preprint":false},{"pmid":"16466692","id":"PMC_16466692","title":"Stimulation of the creatine transporter SLC6A8 by the protein kinase mTOR.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16466692","citation_count":32,"is_preprint":false},{"pmid":"22472424","id":"PMC_22472424","title":"Contiguous deletion of SLC6A8 and BAP31 in a patient with severe dystonia and sensorineural deafness.","date":"2012","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22472424","citation_count":32,"is_preprint":false},{"pmid":"27798759","id":"PMC_27798759","title":"Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT.","date":"2016","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/27798759","citation_count":32,"is_preprint":false},{"pmid":"24022063","id":"PMC_24022063","title":"Loss of all three calreticulins, CRT1, CRT2 and CRT3, causes enhanced sensitivity to water stress in Arabidopsis.","date":"2013","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24022063","citation_count":31,"is_preprint":false},{"pmid":"36246666","id":"PMC_36246666","title":"CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy.","date":"2022","source":"Bioactive materials","url":"https://pubmed.ncbi.nlm.nih.gov/36246666","citation_count":31,"is_preprint":false},{"pmid":"23836438","id":"PMC_23836438","title":"CDX2 regulates multiple trophoblast genes in bovine trophectoderm CT-1 cells.","date":"2013","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/23836438","citation_count":31,"is_preprint":false},{"pmid":"33990217","id":"PMC_33990217","title":"SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/33990217","citation_count":30,"is_preprint":false},{"pmid":"22281021","id":"PMC_22281021","title":"Detection of variants in SLC6A8 and functional analysis of unclassified missense variants.","date":"2012","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22281021","citation_count":30,"is_preprint":false},{"pmid":"10583628","id":"PMC_10583628","title":"Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent.","date":"1999","source":"International journal of experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10583628","citation_count":28,"is_preprint":false},{"pmid":"24597975","id":"PMC_24597975","title":"Genotype-phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1.","date":"2014","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24597975","citation_count":28,"is_preprint":false},{"pmid":"25531585","id":"PMC_25531585","title":"Negative regulation of the creatine transporter SLC6A8 by SPAK and OSR1.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25531585","citation_count":27,"is_preprint":false},{"pmid":"25206338","id":"PMC_25206338","title":"Creatine transporter (SLC6A8) knockout mice display an increased capacity for in vitro creatine biosynthesis in skeletal muscle.","date":"2014","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25206338","citation_count":27,"is_preprint":false},{"pmid":"8661155","id":"PMC_8661155","title":"The genomic organization of a human creatine transporter (CRTR) gene located in Xq28.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8661155","citation_count":27,"is_preprint":false},{"pmid":"17582527","id":"PMC_17582527","title":"Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients.","date":"2007","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/17582527","citation_count":27,"is_preprint":false},{"pmid":"34411157","id":"PMC_34411157","title":"Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: Prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34411157","citation_count":26,"is_preprint":false},{"pmid":"29384270","id":"PMC_29384270","title":"Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8.","date":"2018","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/29384270","citation_count":25,"is_preprint":false},{"pmid":"25861866","id":"PMC_25861866","title":"Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25861866","citation_count":25,"is_preprint":false},{"pmid":"28900723","id":"PMC_28900723","title":"Diagnostic value of sentinel lymph node biopsy for cT1/T2N0 tongue squamous cell carcinoma: a meta-analysis.","date":"2017","source":"European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/28900723","citation_count":24,"is_preprint":false},{"pmid":"15716108","id":"PMC_15716108","title":"Carotenoid biosynthetic pathway: molecular phylogenies and evolutionary behavior of crt genes in eubacteria.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15716108","citation_count":24,"is_preprint":false},{"pmid":"26061142","id":"PMC_26061142","title":"A Nematode Calreticulin, Rs-CRT, Is a Key Effector in Reproduction and Pathogenicity of Radopholus similis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26061142","citation_count":24,"is_preprint":false},{"pmid":"27527604","id":"PMC_27527604","title":"Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.","date":"2016","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/27527604","citation_count":23,"is_preprint":false},{"pmid":"30053596","id":"PMC_30053596","title":"LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30053596","citation_count":22,"is_preprint":false},{"pmid":"20383744","id":"PMC_20383744","title":"Overexpression of CrtR-b2 (carotene beta hydroxylase 2) from S. lycopersicum L. differentially affects xanthophyll synthesis and accumulation in transgenic tomato plants.","date":"2010","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/20383744","citation_count":22,"is_preprint":false},{"pmid":"18812201","id":"PMC_18812201","title":"Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.","date":"2008","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/18812201","citation_count":22,"is_preprint":false},{"pmid":"33708891","id":"PMC_33708891","title":"SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.","date":"2021","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33708891","citation_count":21,"is_preprint":false},{"pmid":"33274496","id":"PMC_33274496","title":"HIF-1α regulates osteoclast activation and mediates osteogenesis during mandibular bone repair via CT-1.","date":"2020","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33274496","citation_count":20,"is_preprint":false},{"pmid":"32207963","id":"PMC_32207963","title":"Classification of the Molecular Defects Associated with Pathogenic Variants of the SLC6A8 Creatine Transporter.","date":"2020","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32207963","citation_count":20,"is_preprint":false},{"pmid":"21144783","id":"PMC_21144783","title":"Language disorder with mild intellectual disability in a child affected by a novel mutation of SLC6A8 gene.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21144783","citation_count":20,"is_preprint":false},{"pmid":"17851862","id":"PMC_17851862","title":"Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis.","date":"2008","source":"Acta oncologica (Stockholm, Sweden)","url":"https://pubmed.ncbi.nlm.nih.gov/17851862","citation_count":20,"is_preprint":false},{"pmid":"16539012","id":"PMC_16539012","title":"Hard tick calreticulin (CRT) gene coding regions have only one intron with conserved positions and variable sizes.","date":"2005","source":"The Journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16539012","citation_count":20,"is_preprint":false},{"pmid":"22897793","id":"PMC_22897793","title":"Modeling the interfacial interactions between CrtS and CrtR from Xanthophyllomyces dendrorhous , a P450 system involved in astaxanthin production.","date":"2012","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22897793","citation_count":19,"is_preprint":false},{"pmid":"33954898","id":"PMC_33954898","title":"Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).","date":"2021","source":"La Radiologia medica","url":"https://pubmed.ncbi.nlm.nih.gov/33954898","citation_count":19,"is_preprint":false},{"pmid":"22407360","id":"PMC_22407360","title":"Downregulation of the creatine transporter SLC6A8 by JAK2.","date":"2012","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/22407360","citation_count":19,"is_preprint":false},{"pmid":"26867947","id":"PMC_26867947","title":"MAZ mediates the cross-talk between CT-1 and NOTCH1 signaling during gliogenesis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26867947","citation_count":18,"is_preprint":false},{"pmid":"24034325","id":"PMC_24034325","title":"Circularized RT-PCR (cRT-PCR): analysis of the 5' ends, 3' ends, and poly(A) tails of RNA.","date":"2013","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/24034325","citation_count":18,"is_preprint":false},{"pmid":"28938593","id":"PMC_28938593","title":"Endoplasmic reticulum stress-mediated membrane expression of CRT/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28938593","citation_count":18,"is_preprint":false},{"pmid":"22869567","id":"PMC_22869567","title":"Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.","date":"2012","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/22869567","citation_count":18,"is_preprint":false},{"pmid":"31071544","id":"PMC_31071544","title":"Biopriming of maize germination by the plant growth-promoting rhizobacterium Azospirillum lipoferum CRT1.","date":"2019","source":"Journal of plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31071544","citation_count":17,"is_preprint":false},{"pmid":"34412929","id":"PMC_34412929","title":"Tumor-stroma ratio is a crucial histological predictor of occult cervical lymph node metastasis and survival in early-stage (cT1/2N0) oral squamous cell carcinoma.","date":"2021","source":"International journal of oral and maxillofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/34412929","citation_count":17,"is_preprint":false},{"pmid":"33168336","id":"PMC_33168336","title":"Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma.","date":"2020","source":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33168336","citation_count":17,"is_preprint":false},{"pmid":"10556033","id":"PMC_10556033","title":"The dimerization/repression domain of RFX1 is related to a conserved region of its yeast homologues Crt1 and Sak1: a new function for an ancient motif.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10556033","citation_count":16,"is_preprint":false},{"pmid":"28285145","id":"PMC_28285145","title":"Treatment effects of Cardiotrophin-1 (CT-1) on streptozotocin-induced memory deficits in mice.","date":"2017","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/28285145","citation_count":16,"is_preprint":false},{"pmid":"22644605","id":"PMC_22644605","title":"Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome.","date":"2012","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/22644605","citation_count":16,"is_preprint":false},{"pmid":"32751941","id":"PMC_32751941","title":"Corynebacterium glutamicum CrtR and Its Orthologs in Actinobacteria: Conserved Function and Application as Genetically Encoded Biosensor for Detection of Geranylgeranyl Pyrophosphate.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32751941","citation_count":15,"is_preprint":false},{"pmid":"30448873","id":"PMC_30448873","title":"Available ablation energies to treat cT1 renal cell cancer: emerging technologies.","date":"2018","source":"World journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/30448873","citation_count":15,"is_preprint":false},{"pmid":"17578704","id":"PMC_17578704","title":"Molecular phylogenies and evolution of crt genes in algae.","date":"2007","source":"Critical reviews in biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/17578704","citation_count":15,"is_preprint":false},{"pmid":"31542396","id":"PMC_31542396","title":"Creatine transporter knockout mice (Slc6a8) show increases in serotonin-related proteins and are resilient to learned helplessness.","date":"2019","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31542396","citation_count":15,"is_preprint":false},{"pmid":"17486546","id":"PMC_17486546","title":"Spatiotemporal expression of the creatine metabolism related genes agat, gamt and ct1 during zebrafish embryogenesis.","date":"2007","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17486546","citation_count":15,"is_preprint":false},{"pmid":"35102568","id":"PMC_35102568","title":"Trends in Positive Surgical Margins in cT1-T2 Oral Cavity Squamous Cell Carcinoma.","date":"2022","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/35102568","citation_count":15,"is_preprint":false},{"pmid":"14555790","id":"PMC_14555790","title":"The cardioprotective agent urocortin induces expression of CT-1.","date":"2003","source":"Cardiovascular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/14555790","citation_count":15,"is_preprint":false},{"pmid":"22311562","id":"PMC_22311562","title":"Transcriptome, proteome, and metabolome in dyssynchronous heart failure and CRT.","date":"2012","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/22311562","citation_count":14,"is_preprint":false},{"pmid":"19567229","id":"PMC_19567229","title":"Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: a Philippine study.","date":"2009","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/19567229","citation_count":14,"is_preprint":false},{"pmid":"30938090","id":"PMC_30938090","title":"The mechanical effects of CRT promoting autophagy via mitochondrial calcium uniporter down-regulation and mitochondrial dynamics alteration.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30938090","citation_count":14,"is_preprint":false},{"pmid":"27813185","id":"PMC_27813185","title":"New orally active DNA minor groove binding small molecule CT-1 acts against breast cancer by targeting tumor DNA damage leading to p53-dependent apoptosis.","date":"2016","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/27813185","citation_count":14,"is_preprint":false},{"pmid":"36881167","id":"PMC_36881167","title":"Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma.","date":"2023","source":"European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/36881167","citation_count":12,"is_preprint":false},{"pmid":"26666525","id":"PMC_26666525","title":"Regulation of the Na+,Cl- Coupled Creatine Transporter CreaT (SLC6A8) by the Janus Kinase JAK3.","date":"2015","source":"Neuro-Signals","url":"https://pubmed.ncbi.nlm.nih.gov/26666525","citation_count":12,"is_preprint":false},{"pmid":"19583800","id":"PMC_19583800","title":"Applicability of the 16S-23S rDNA internal spacer for PCR detection of the phytostimulatory PGPR inoculant Azospirillum lipoferum CRT1 in field soil.","date":"2010","source":"Journal of applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19583800","citation_count":12,"is_preprint":false},{"pmid":"30400883","id":"PMC_30400883","title":"A novel SLC6A8 mutation associated with intellectual disabilities in a Chinese family exhibiting creatine transporter deficiency: case report.","date":"2018","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30400883","citation_count":12,"is_preprint":false},{"pmid":"38070861","id":"PMC_38070861","title":"Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8.","date":"2023","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38070861","citation_count":11,"is_preprint":false},{"pmid":"34637145","id":"PMC_34637145","title":"Sentinel Lymph Node Biopsy Versus Elective Node Dissection in Stage cT1-2N0 Oral Cavity Cancer.","date":"2021","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/34637145","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53461,"output_tokens":5822,"usd":0.123856},"stage2":{"model":"claude-opus-4-6","input_tokens":9424,"output_tokens":3657,"usd":0.207817},"total_usd":0.331673,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"SLC6A8 encodes a creatine transporter whose loss-of-function (hemizygous nonsense mutation) causes cerebral creatine deficiency; fibroblasts from the index patient were defective in creatine uptake, establishing SLC6A8 as the gene responsible for X-linked creatine transporter deficiency syndrome.\",\n      \"method\": \"Fibroblast creatine uptake assay, mutation analysis (nonsense mutation in SLC6A8), proton MRS\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional loss-of-function assay in patient fibroblasts with direct biochemical readout, foundational paper replicated widely\",\n      \"pmids\": [\"11326334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human SLC6A8 (CRT-1) expressed in Xenopus oocytes mediates Na+- and Cl−-dependent concentrative creatine uptake with Km ~20 µM; transport requires at least two Na+ ions and one Cl− ion per creatine molecule; activity is inhibited by beta-guanidinopropionic acid, cyclocreatine, and amiloride; protein kinase C activation (PMA) inhibits transport while PKA activation does not.\",\n      \"method\": \"Xenopus oocyte expression system, radiolabeled creatine uptake assay, ion-substitution kinetics, pharmacological inhibitors, phorbol ester treatment\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted transport in heterologous system with detailed kinetic and pharmacological characterization\",\n      \"pmids\": [\"9882430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The SLC6A8 (CRTR) gene is located at Xq28, contains 13 exons spanning ~8.5 kb of genomic DNA, approximately 36 kb centromeric to the ALD gene.\",\n      \"method\": \"Large-scale genomic sequencing, gene structure analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct genomic sequencing establishing gene organization\",\n      \"pmids\": [\"8661155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SLC6A8 creatine transport activity in Xenopus oocytes is stimulated by co-expression of SGK1 (serum- and glucocorticoid-inducible kinase 1) and SGK3, but not by SGK2 or PKB; constitutively active SGK1/SGK3 increase maximal transport rate without altering creatine affinity.\",\n      \"method\": \"Xenopus oocyte expression system, two-electrode voltage-clamp electrophysiology, kinetic analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electrophysiological reconstitution with kinase-inactive mutant controls\",\n      \"pmids\": [\"16036218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"mTOR stimulates SLC6A8 creatine transport activity in Xenopus oocytes, increasing maximal transport rate; this effect is blocked by rapamycin and by inactive SGK1, indicating mTOR acts at least partially through SGK1.\",\n      \"method\": \"Xenopus oocyte expression system, two-electrode voltage-clamp, rapamycin inhibition\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electrophysiological reconstitution with pharmacological and dominant-negative controls\",\n      \"pmids\": [\"16466692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PIKfyve (PIP5K3) mediates SGK1-dependent stimulation of SLC6A8 in Xenopus oocytes; SGK1 phosphorylates PIKfyve at its consensus serine (S318), and a S318A-PIKfyve mutant abolishes both PIKfyve- and SGK1-stimulated SLC6A8 activity, establishing PIKfyve as an intermediate in the SGK1→SLC6A8 regulatory axis.\",\n      \"method\": \"Xenopus oocyte co-expression, two-electrode voltage-clamp, site-directed mutagenesis (S318A PIKfyve)\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted pathway with mutagenesis identifying specific phosphorylation site\",\n      \"pmids\": [\"17982255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Missense variants in SLC6A8 were functionally classified by site-directed mutagenesis and transient transfection into SLC6A8-deficient fibroblasts; nine variants (p.Gly87Arg, p.Phe107del, p.Tyr317X, p.Asn336del, p.Cys337Trp, p.Ile347del, p.Pro390Leu, p.Arg391Trp, p.Pro554Leu) were proven pathogenic (loss of creatine uptake) and four were nonpathogenic.\",\n      \"method\": \"Site-directed mutagenesis, transient transfection, creatine uptake assay in SLC6A8-deficient fibroblasts\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay with mutagenesis across multiple variants, direct transport readout\",\n      \"pmids\": [\"17465020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"JAK2 downregulates SLC6A8 creatine transport in Xenopus oocytes; constitutively active (V617F)JAK2 but not kinase-dead (K882E)JAK2 reduces maximal transport rate; JAK2 inhibitor AG490 reverses this suppression; brefeldin A experiments indicate JAK2 does not alter carrier membrane half-life, suggesting interference with carrier insertion into the plasma membrane.\",\n      \"method\": \"Xenopus oocyte expression, two-electrode voltage-clamp, constitutively active and kinase-dead JAK2 mutants, brefeldin A trafficking assay, pharmacological inhibition\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electrophysiological reconstitution with mutagenesis and trafficking assay\",\n      \"pmids\": [\"22407360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Four non-truncating SLC6A8 mutations abolish both electrogenic creatine transport and creatine uptake in Xenopus oocytes and patient fibroblasts; all mutant proteins are properly targeted to the plasma membrane, indicating a functional defect rather than a trafficking defect; guanidinopropionate activates wild-type SLC6A8 electrogenically similar to creatine, while a phosphocreatine derivative (PCr-Mg-CPLX) shows only partial activity.\",\n      \"method\": \"Xenopus oocyte electrophysiology, [14C]-creatine uptake, immunofluorescence, western blot, subcellular localization\",\n      \"journal\": \"Journal of inherited metabolic disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multi-method functional and localization study with patient-derived fibroblasts and heterologous system\",\n      \"pmids\": [\"22644605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SPAK (constitutively active T233E form, requires catalytic activity) and OSR1 (wild-type, T185E, T185A forms, requires catalytic activity) negatively regulate SLC6A8 by decreasing maximal transport rate in Xenopus oocytes.\",\n      \"method\": \"Xenopus oocyte expression, two-electrode voltage-clamp, constitutively active and kinase-dead mutants of SPAK and OSR1\",\n      \"journal\": \"Kidney & blood pressure research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electrophysiological reconstitution with multiple kinase mutants\",\n      \"pmids\": [\"25531585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Klotho protein upregulates SLC6A8 creatine transporter activity in Xenopus oocytes by stabilizing the carrier in the plasma membrane (assessed by delayed brefeldin A-induced current decline); the effect requires Klotho's β-glucuronidase activity and is reproduced by recombinant soluble Klotho.\",\n      \"method\": \"Xenopus oocyte co-expression, two-electrode voltage-clamp, brefeldin A membrane insertion assay, β-glucuronidase inhibitor (DSAL), recombinant Klotho protein\",\n      \"journal\": \"Kidney & blood pressure research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electrophysiological reconstitution with mechanistic trafficking dissection\",\n      \"pmids\": [\"25531216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"JAK3 negatively regulates SLC6A8 creatine transport in Xenopus oocytes; constitutively active A568V JAK3 but not kinase-dead K851A JAK3 decreases maximal creatine transport rate; the JAK3 inhibitor WHI-P154 reverses suppression.\",\n      \"method\": \"Xenopus oocyte expression, two-electrode voltage-clamp, constitutively active and kinase-dead JAK3 mutants, pharmacological inhibition\",\n      \"journal\": \"Neuro-Signals\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — electrophysiological reconstitution with mutagenesis and pharmacological validation\",\n      \"pmids\": [\"26666525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In the CNS, SLC6A8 is absent from astrocytes surrounding the blood-brain barrier, limiting creatine import from the periphery; furthermore, AGAT and GAMT are largely expressed in distinct (non-overlapping) brain cell populations, and brain cells take up guanidinoacetate and convert it to creatine via SLC6A8-mediated intercellular transport, explaining why SLC6A8 deficiency causes cerebral creatine deficiency despite intact AGAT and GAMT expression.\",\n      \"method\": \"Immunohistochemistry/in situ hybridization for AGAT, GAMT, SLC6A8 co-expression analysis; reaggregating brain cell cultures with radiolabeled guanidinoacetate uptake and competition assays\",\n      \"journal\": \"Journal of inherited metabolic disease / Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct cell-type co-expression mapping plus functional guanidinoacetate uptake in brain cell cultures, replicated across two papers from same lab\",\n      \"pmids\": [\"18392746\", \"19879361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ubiquitous Slc6a8 knockout mice lack creatine in brain and muscle and show learning/memory deficits (Morris water maze, novel object recognition, fear conditioning) with increased serotonin and 5-HIAA in hippocampus and prefrontal cortex, establishing SLC6A8 as required for creatine uptake in vivo and linking brain creatine to cognitive function.\",\n      \"method\": \"Cre-loxP knockout mouse (exons 2–4 deleted), HPLC-based creatine measurement, Morris water maze, novel object recognition, conditioned fear, neurotransmitter quantification\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple behavioral and biochemical phenotypic readouts\",\n      \"pmids\": [\"21249153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Brain-specific Slc6a8 knockout (Nestin-Cre) mice have reduced cerebral creatine with normal peripheral creatine and display cognitive deficits (Morris water maze, novel object recognition, fear conditioning) and hyperactivity; brain guanidinoacetate (creatine synthesis precursor) is increased, confirming SLC6A8 is required for cerebral creatine homeostasis and that loss of brain creatine alone is sufficient to cause the cognitive phenotype.\",\n      \"method\": \"Nestin-Cre conditional KO, creatine/guanidinoacetate tissue measurement, Morris water maze, novel object recognition, fear conditioning, open field\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — brain-specific KO with multiple orthogonal behavioral and metabolic readouts, dissociates central from peripheral effects\",\n      \"pmids\": [\"29384270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SLC6A8 knockout mouse skeletal muscle retains measurable but markedly reduced creatine (~18% of WT); AGAT protein expression and in vitro creatine biosynthesis rates are upregulated ~3-fold and ~1.5-fold respectively in KO muscle, demonstrating compensatory induction of local creatine synthesis when SLC6A8-mediated uptake is lost.\",\n      \"method\": \"Whole-body CrT KO mice, HPLC creatine measurement, western blot (AGAT/GAMT protein), qPCR, in vitro creatine biosynthesis assay\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO model with multiple orthogonal biochemical methods\",\n      \"pmids\": [\"25206338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Macrophage Slc6a8-mediated creatine uptake reprograms macrophage polarization: creatine suppresses M(IFN-γ) (M1) effector functions by inhibiting IFN-γ-JAK-STAT1 signaling and supports M(IL-4) (M2) functions by promoting chromatin remodeling at STAT6 targets; ablation of Slc6a8 in macrophages alters these immune responses in vivo.\",\n      \"method\": \"Genetic Slc6a8 ablation in macrophages, cytokine stimulation assays, STAT1/STAT6 signaling analysis, chromatin remodeling assays, in vivo macrophage functional studies\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with mechanistic signaling pathway dissection and in vivo validation, high-citation study\",\n      \"pmids\": [\"31399282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RGX-202, a small-molecule SLC6A8 inhibitor, blocks creatine import, reduces intracellular phosphocreatine and ATP, induces tumor apoptosis, and suppresses colorectal cancer growth in xenograft, syngeneic, and PDX models; antitumor efficacy correlates with creatine kinase B expression; combination with 5-FU or the DHODH inhibitor leflunomide causes tumor regressions.\",\n      \"method\": \"In vitro creatine transport inhibition assay, xenograft/syngeneic/PDX mouse tumor models, metabolite measurement (phosphocreatine, ATP), apoptosis assays, phase 1 clinical pharmacodynamics\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo tumor models plus human pharmacodynamic confirmation, mechanism linked to transporter inhibition\",\n      \"pmids\": [\"34613776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Leukemic cell-derived small extracellular vesicles carrying miR-19a-3p are internalized by CD8+ T cells and directly repress SLC6A8 expression, inhibiting creatine import, reducing ATP production, and impairing CD8+ T cell immune function, leading to immune escape by NPM1-mutated AML cells.\",\n      \"method\": \"sEV co-culture system, miR-19a-3p overexpression/inhibition, SLC6A8 reporter assay, creatine/ATP measurement, CD8+ T cell functional assays\",\n      \"journal\": \"Journal of extracellular vesicles\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway established in co-culture system with multiple readouts, single lab\",\n      \"pmids\": [\"34807526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Quantitative profiling of eight pathogenic SLC6A8 variants shows all exhibit proteostatic deficiencies (reduced expression/trafficking); two variants primarily disrupt the substrate-binding pocket (distinct from trafficking defects); structural modeling identifies mechanistic classes; 4-PBA (proteostasis regulator) enhances WT SLC6A8 activity in HEK293T cells.\",\n      \"method\": \"Transient transfection in HEK293T, creatine uptake assay, cell surface trafficking/expression quantification, structural homology modeling, temperature sensitivity assay, 4-PBA treatment, site-directed mutagenesis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (functional assay, trafficking, structural modeling, mutagenesis) in single study\",\n      \"pmids\": [\"32207963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mass spectrometry interactome of WT SLC6A8 in HEK293T cells identified binding partners; pathogenic variants lead to enrichment of ER protein partners (retention), and two variants disrupt protein–protein interaction interfaces as revealed by in silico complex modeling; homology models of inward-facing and outward-facing conformations used to classify variant effects on the transport cycle.\",\n      \"method\": \"Co-immunoprecipitation mass spectrometry, homology modeling (inward/outward conformations), creatine uptake assay, subcellular localization (immunofluorescence), thermodynamic stability prediction\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — MS interactome plus structural models plus functional assays; integrated multi-method study\",\n      \"pmids\": [\"38070861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SLC6A8 is transcriptionally upregulated by p65/NF-κB in hypoxic triple-negative breast cancer cells; SLC6A8-mediated creatine accumulation reduces mitochondrial activity and oxygen consumption, lowers ROS, and activates AKT-ERK signaling to promote survival (upregulation of Ki-67, Bcl-2; downregulation of Bax, cleaved Caspase-3).\",\n      \"method\": \"RNA-seq, siRNA knockdown, creatine uptake measurement, ROS assay, mitochondrial OCR measurement, AKT/ERK signaling western blot, xenograft mouse model\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro and in vivo methods with mechanistic signaling readouts, single lab\",\n      \"pmids\": [\"33990217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Spatiotemporal expression of ct1 (SLC6A8 ortholog) in zebrafish embryos shows initial ubiquitous expression followed by strong expression in somites and gut, with expression in the central nervous system during segmentation but not in yolk or liver — distinct from the co-expressed creatine synthesis enzymes agat and gamt.\",\n      \"method\": \"Whole-mount in situ hybridization with histological sectioning in zebrafish embryos\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization experiment establishing tissue-specific expression pattern, zebrafish ortholog\",\n      \"pmids\": [\"17486546\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC6A8 encodes a Na+- and Cl−-dependent creatine transporter (requiring ≥2 Na+ and 1 Cl− per creatine molecule, Km ~20 µM) that is the primary route for concentrative creatine uptake in brain, muscle, heart, and immune cells; its transport activity is positively regulated by SGK1/SGK3 (acting via PIKfyve phosphorylation) and mTOR, and negatively regulated by SPAK, OSR1, JAK2, and JAK3; Klotho stabilizes SLC6A8 in the plasma membrane via β-glucuronidase activity; in the CNS, SLC6A8 also transports the creatine precursor guanidinoacetate between AGAT- and GAMT-expressing cells to support local creatine synthesis, and loss of SLC6A8 causes cerebral creatine deficiency and cognitive deficits; in macrophages, SLC6A8-mediated creatine uptake reprograms polarization by modulating IFN-γ-JAK-STAT1 and IL-4-STAT6 signaling; pathogenic mutations cause defects spanning substrate-binding pocket disruption, ER retention, and other proteostatic mechanisms.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SLC6A8 is a Na⁺/Cl⁻-dependent creatine transporter that mediates concentrative creatine uptake in brain, muscle, heart, and immune cells, requiring at least two Na⁺ ions and one Cl⁻ ion per creatine molecule with a Km of ~20 µM [PMID:9882430]. Its transport activity is positively regulated by SGK1/SGK3 (via PIKfyve phosphorylation at S318) and mTOR, and negatively regulated by SPAK, OSR1, JAK2, and JAK3, while Klotho stabilizes the transporter at the plasma membrane through its β-glucuronidase activity [PMID:16036218, PMID:17982255, PMID:16466692, PMID:25531585, PMID:22407360, PMID:25531216]. Loss-of-function mutations in SLC6A8 cause X-linked creatine transporter deficiency, characterized by cerebral creatine depletion and cognitive impairment; in the CNS, SLC6A8 also transports guanidinoacetate between AGAT- and GAMT-expressing cells to support local creatine biosynthesis, and its absence from blood-brain barrier astrocytes limits peripheral creatine import [PMID:11326334, PMID:18392746, PMID:29384270]. In macrophages, SLC6A8-mediated creatine uptake reprograms polarization by suppressing IFN-γ–JAK–STAT1 signaling and promoting IL-4–STAT6-driven chromatin remodeling, and in cancer cells, creatine import through SLC6A8 supports bioenergetics and survival under hypoxia [PMID:31399282, PMID:34613776, PMID:33990217].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing the genomic organization of SLC6A8 at Xq28 provided the structural framework necessary for subsequent mutation screening and disease gene identification.\",\n      \"evidence\": \"Large-scale genomic sequencing defined 13 exons spanning ~8.5 kb at Xq28\",\n      \"pmids\": [\"8661155\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional data on transport at this stage\", \"Regulatory elements not mapped\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Reconstitution of human SLC6A8 in Xenopus oocytes defined the fundamental transport mechanism — Na⁺/Cl⁻-dependent concentrative creatine uptake with ~20 µM affinity — and established the heterologous expression system used in most subsequent regulatory studies.\",\n      \"evidence\": \"Radiolabeled creatine uptake and ion-substitution kinetics in Xenopus oocytes expressing human SLC6A8\",\n      \"pmids\": [\"9882430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the transporter unknown\", \"In vivo relevance not yet demonstrated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of a hemizygous nonsense mutation in a patient with cerebral creatine deficiency proved that SLC6A8 loss of function is the genetic basis of X-linked creatine transporter deficiency, converting a biochemical activity into a disease gene.\",\n      \"evidence\": \"Mutation analysis and fibroblast creatine uptake assay in index patient, confirmed by proton MRS\",\n      \"pmids\": [\"11326334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype–phenotype correlation across variant classes not established\", \"Blood-brain barrier mechanism not yet addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that SGK1/SGK3 stimulate SLC6A8 maximal transport rate without altering substrate affinity opened the field of kinase-mediated transporter regulation and was subsequently extended to a PIKfyve→SGK1 axis and mTOR signaling.\",\n      \"evidence\": \"Xenopus oocyte electrophysiology with co-expressed constitutively active SGK isoforms; PIKfyve S318A mutagenesis; rapamycin and dominant-negative SGK1 experiments\",\n      \"pmids\": [\"16036218\", \"17982255\", \"16466692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether these regulatory mechanisms operate in native tissues is untested\", \"Direct phosphorylation of SLC6A8 itself not demonstrated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Systematic functional classification of pathogenic missense variants revealed that loss of creatine uptake can arise from either trafficking failure or substrate-binding-pocket disruption, establishing mechanistic heterogeneity among disease alleles.\",\n      \"evidence\": \"Site-directed mutagenesis and creatine uptake assay in SLC6A8-deficient fibroblasts for 13 variants\",\n      \"pmids\": [\"17465020\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model to explain residue-level defects\", \"No attempt at pharmacological rescue\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Cell-type mapping in the CNS revealed that SLC6A8 is absent from blood-brain barrier astrocytes and that AGAT and GAMT are expressed in distinct brain cell populations, establishing that SLC6A8 transports guanidinoacetate between cells to enable local creatine synthesis — explaining why SLC6A8 deficiency causes cerebral creatine depletion despite intact synthetic enzymes.\",\n      \"evidence\": \"Immunohistochemistry/in situ hybridization co-expression mapping and radiolabeled guanidinoacetate uptake in reaggregating brain cell cultures\",\n      \"pmids\": [\"18392746\", \"19879361\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of intercellular guanidinoacetate transport vs. direct creatine import not quantified\", \"No genetic manipulation of BBB astrocytes\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Ubiquitous Slc6a8 knockout mice confirmed that SLC6A8 is essential for creatine uptake in vivo, with complete brain and muscle creatine loss causing learning/memory deficits and serotonergic neurotransmitter imbalance.\",\n      \"evidence\": \"Cre-loxP global KO with HPLC creatine measurement, Morris water maze, novel object recognition, conditioned fear, and hippocampal neurotransmitter quantification\",\n      \"pmids\": [\"21249153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of peripheral vs. central creatine loss to cognitive deficits not dissociated\", \"Mechanism linking creatine to serotonin metabolism unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"JAK2 was identified as a negative regulator that reduces SLC6A8 maximal transport by inhibiting carrier insertion into the plasma membrane (not by accelerating removal), introducing a new regulatory axis distinct from SGK1/mTOR-mediated stimulation.\",\n      \"evidence\": \"Xenopus oocyte electrophysiology with constitutively active V617F and kinase-dead K882E JAK2; brefeldin A trafficking assay\",\n      \"pmids\": [\"22407360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"JAK2 regulation not validated in mammalian cells\", \"Direct vs. indirect mechanism on SLC6A8 not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Additional negative regulators SPAK and OSR1 and a positive stabilizer Klotho were identified, expanding the kinase/enzyme network controlling SLC6A8 surface density and maximal transport rate.\",\n      \"evidence\": \"Xenopus oocyte electrophysiology with constitutively active/kinase-dead SPAK and OSR1 mutants; Klotho co-expression with brefeldin A membrane stability assay and β-glucuronidase inhibitor\",\n      \"pmids\": [\"25531585\", \"25531216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of Klotho-SLC6A8 axis unconfirmed\", \"Mechanism by which β-glucuronidase activity stabilizes SLC6A8 at the membrane is unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Brain-specific Slc6a8 knockout dissociated central from peripheral effects, proving that loss of cerebral creatine alone — independent of muscle/systemic creatine — is sufficient to cause cognitive deficits and hyperactivity.\",\n      \"evidence\": \"Nestin-Cre conditional KO with tissue creatine/guanidinoacetate measurement and behavioral testing (Morris water maze, novel object recognition, fear conditioning, open field)\",\n      \"pmids\": [\"29384270\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific roles in neurons vs. oligodendrocytes not resolved\", \"Therapeutic rescue by creatine supplementation not tested in this model\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"SLC6A8-mediated creatine uptake was shown to directly reprogram macrophage polarization by inhibiting IFN-γ–JAK–STAT1 signaling and promoting IL-4–STAT6 chromatin remodeling, establishing a non-neuronal, immunometabolic function for SLC6A8.\",\n      \"evidence\": \"Macrophage-specific Slc6a8 ablation with cytokine stimulation, STAT1/STAT6 signaling, chromatin remodeling assays, and in vivo functional studies\",\n      \"pmids\": [\"31399282\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact metabolic intermediates through which creatine modulates JAK-STAT signaling not identified\", \"Role in adaptive immunity beyond macrophages only partially explored\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Quantitative profiling of pathogenic variants established that all tested disease mutations exhibit proteostatic deficiencies (reduced expression or trafficking), while a subset additionally disrupts the substrate-binding pocket — classifying disease mechanisms into trafficking-defective and binding-defective categories and identifying 4-PBA as a potential proteostasis-based corrector.\",\n      \"evidence\": \"Creatine uptake, cell-surface trafficking quantification, structural homology modeling, temperature sensitivity, and 4-PBA treatment in HEK293T cells\",\n      \"pmids\": [\"32207963\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"4-PBA efficacy on patient-derived cells not tested\", \"No experimental structure to validate homology models\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"SLC6A8 emerged as a cancer-relevant transporter: pharmacological inhibition by RGX-202 depleted intracellular phosphocreatine/ATP and suppressed colorectal cancer growth across multiple in vivo models, while in triple-negative breast cancer SLC6A8 was transcriptionally upregulated by NF-κB under hypoxia to promote survival via AKT-ERK signaling.\",\n      \"evidence\": \"RGX-202 transport inhibition assay, xenograft/syngeneic/PDX models, metabolite measurement; siRNA knockdown in TNBC cells with ROS/OCR measurement and xenograft\",\n      \"pmids\": [\"34613776\", \"33990217\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity of RGX-202 for SLC6A8 over other SLC6 family members not fully characterized\", \"Clinical efficacy data pending\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mass spectrometry interactomics of WT and mutant SLC6A8 revealed that pathogenic variants enrich ER-resident binding partners (consistent with ER retention) and that specific variants disrupt protein–protein interaction interfaces, providing a molecular explanation for variant-specific trafficking failure.\",\n      \"evidence\": \"Co-immunoprecipitation mass spectrometry in HEK293T, homology modeling of inward/outward-facing conformations, functional assays\",\n      \"pmids\": [\"38070861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interactome not validated by reciprocal pulldown or proximity labeling\", \"Cryo-EM or crystal structure of SLC6A8 still lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the high-resolution structure of SLC6A8 in multiple conformational states, the direct phosphorylation events on SLC6A8 itself (if any) underlying kinase regulation, the molecular basis of guanidinoacetate vs. creatine selectivity, and whether pharmacological chaperones can rescue trafficking-defective variants in patients.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental atomic-resolution structure\", \"Direct post-translational modification sites on SLC6A8 unmapped\", \"Therapeutic rescue strategy for trafficking-defective mutations untested in vivo\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 0, 8, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 8, 10, 19, 20]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [19, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 0, 8]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 15, 17]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 5, 7, 9, 11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SGK1\",\n      \"SGK3\",\n      \"PIKfyve\",\n      \"MTOR\",\n      \"JAK2\",\n      \"JAK3\",\n      \"SPAK\",\n      \"OSR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}